Randomized Phase II Study of Durvalumab with or Without Tremelimumab in Patients with Metastatic Castration Resistant Prostate Cancer.
Eric Winquist,Sebastien J. Hotte,Kim Chi,Srikala Sridhar,Susan Ellard,Michael Ong,Nayyer Iqbal,Muhammad Salim,Urban Emmenegger,Joel R. Gingerich, Aly-Khan Lalani,Pierre Major,Christian Kollmannsberger,Steven Yip,Aaron Hansen,Daygen Finch,Christina Canil, James Hutchenreuther, Francisco Vera-Badillo,Martin Smoragiewicz,Michael Cabanero,Ming-Sound Tsao,Elie Ritch,Alexander W. Wyatt,Lesley Seymour CLINICAL CANCER RESEARCH（2025）
AI 理解论文
溯源树
样例
